| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RAPID COMMUNICATIONS |
Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo and Kaleida Health, Buffalo, New York 14209
Abstract
Having demonstrated recently that hydrocortisone (HC) suppresses
intranuclear and total cellular nuclear factor-
B (NF-
B) and
increases inhibitor
B (I
B) in mononuclear cells (MNC), in
vivo, we have now investigated the effect of hydrocortisone on
the other major pro-inflammatory transcription factor, AP-1 and the two
proteins, MMP-2 and MMP-9, whose transcription is modulated by it.
MMPs hydrolyze extracellular matrix proteins and thus, allow the
spread of inflammation. HC (100 mg) was given intravenously to eight
normal subjects following an overnight fast. Blood samples were
obtained at 0, 1, 2, 4, 8 and 24 h. MNC were separated and the nuclear
fractions and cellular homogenates were prepared by standard
techniques. AP-1 binding activity was measured by electrophoretic
mobility shift assay (EMSA). Plasma MMP-2 and MMP-9 were measured by
ELISA. AP-1 binding activity fell significantly at 1, 2, 4 and 8 h.
Plasma MMP-2 concentration also decreased significantly at 1, 2, 4 and
8 h while MMP-9 decreased at 1 and 2 h. These data demonstrate that the
acute anti-inflammatory effect of HC, in vivo, is, in
part, due to AP-1 suppression and a reduction in MMP-2 and MMP-9. Thus,
HC may reduce the extracellular spread of inflammation through the
inhibition of matrix metalloproteinases.
This article has been cited by other articles:
![]() |
R. Mukherjee, J. T. Mingoia, J. A. Bruce, J. S. Austin, R. E. Stroud, G. P. Escobar, D. M. McClister Jr, C. M. Allen, M. A. Alfonso-Jaume, M. E. Fini, et al. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2216 - H2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Girod and D. J. Brotman Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res, November 1, 2004; 64(2): 217 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dandona, A. Aljada, A. Chaudhuri, and A. Bandyopadhyay The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2422 - 2429. [Full Text] [PDF] |
||||
![]() |
P. Dandona, A. Aljada, and A. Bandyopadhyay The Potential Therapeutic Role of Insulin in Acute Myocardial Infarction in Patients Admitted to Intensive Care and in Those With Unspecified Hyperglycemia Diabetes Care, February 1, 2003; 26(2): 516 - 519. [Full Text] [PDF] |
||||
![]() |
S. Bozinovski, J. E. Jones, R. Vlahos, J. A. Hamilton, and G. P. Anderson Granulocyte/Macrophage-Colony-stimulating Factor (GM-CSF) Regulates Lung Innate Immunity to Lipopolysaccharide through Akt/Erk Activation of NFkappa B and AP-1 in Vivo J. Biol. Chem., November 1, 2002; 277(45): 42808 - 42814. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Koebernick, L. Grode, J. R. David, W. Rohde, M. S. Rolph, H.-W. Mittrucker, and S. H. E. Kaufmann Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium PNAS, October 15, 2002; 99(21): 13681 - 13686. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |